Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 775 of 2406 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/09/25
End: 05/09/30
Due: 05/09/31
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 08/31/09
Due: 08/31/10
Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC
Phase: N/A
Priority: Normal
Start: 05/31/00
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 11/01/11
End: 05/31/18
Due: 05/31/19
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 03/31/08
Due: 03/31/09
Phase: N/A
Priority: Normal
Start: 03/31/18
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 01/31/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 08/31/04
End: 12/31/06
Due: 12/31/07
Phase: N/A
Priority: Normal
Start: 06/25/18
End: 06/25/24
Due: 06/25/25
Phase: N/A
Priority: Normal
Start: 09/15/17
End: 08/16/22
Due: 08/16/23
Phase: N/A
Priority: Normal
Start: 12/31/05
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 10/31/14
Due: 10/31/15
Phase: N/A
Priority: Normal
Start: 04/09/24
End: 01/29/26
Due: 01/29/27
Phase: N/A
Priority: Normal
Start: 04/21/20
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 02/10/23
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 12/31/16
Due: 12/31/17